The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
The high cost of GLP-1 drugs are increasing pressure on state Medicaid programs — and in response, some cities and states are beginning to restrict or eliminate coverage.
News Apr 10, 2026AbbVie and Genentech have joined TrumpRx, bringing the total number of participating companies to 11 and the total number of drugs available through the platform to 69.
News Apr 3, 2026President Trump unveiled 100% tariffs on patented medications and their active ingredients in a move that could raise costs for patients.
News Mar 27, 2026A new P4AD analysis found that pharmaceutical companies raised prices on 208 rare disease drugs in the first week of the year, just months after the ORPHAN Cures Act was signed into law, weakening…
News Mar 20, 2026P4AD’s new analysis exposes a troubling pattern: pharmaceutical companies are raising prices on lifesaving HIV medications year after year, while simultaneously pushing to undermine reforms that…
News Mar 13, 2026In the last year, 29% of Americans delayed taking a vacation, 26% delayed medical treatment, and 11% skipped meals, all due to the high cost of healthcare.
News Mar 6, 2026The Trump administration has promoted its Most Favored Nation agreements with pharmaceutical companies as a breakthrough on drug pricing, but recent SEC filings reveal that at least some of the 16…
News Feb 27, 2026The proposed GLOBE and GUARD models are mandatory CMMI programs with savings potential for the Medicare program.
News Feb 13, 2026A recent report from DLA Piper argues that Medicare drug price negotiation is failing to deliver meaningful savings to seniors, but the analysis relies on false assumptions and flawed methodology…
News Feb 6, 2026The Trump administration rolled out TrumpRx.gov, a new federal website intended to connect patients with manufacturer discounts on roughly 40 prescription drugs.
